What is Olympus Corporation (OLYMY)?

Olympus Corporation (OLYMY) is a stock in the Healthcare sector, Medical - Devices industry. View full analysis on Stocks360.

What is the current price of OLYMY?

The current price of OLYMY is $10.94. Prices are updated in real time on Stocks360.

What is OLYMY's price-to-earnings (PE) ratio?

OLYMY's trailing twelve-month PE ratio is 24.48, based on current price and earnings per share data available on Stocks360.

What is OLYMY's market capitalization?

OLYMY's market capitalization is $11,627,294,035.00, placing it in the large-cap tier.

Does OLYMY pay a dividend?

Yes. OLYMY has a trailing twelve-month dividend yield of 0.03%. Dividend data is sourced from financial market providers and displayed on Stocks360.

Olympus Corporation (OLYMY)

Stock analysis · OTC · Healthcare · Medical - Devices

$10.94

Market Cap

$11.63B

PE (TTM)

24.48

EPS (TTM)

N/A

Dividend Yield

3.44%

Beta

0.21

Day Range

$10.94 – $11.03

52-wk Range

$8.08 – $13.73

Avg Volume

N/A

Volume

752.00

Olympus Corporation (OLYMY) is a publicly traded company in the Healthcare sector. Latest price: $10.94. Market cap $11.63B. Trailing PE 24.48. Dividend yield 3.44%. Sign in to Stocks360 for full DCF valuation, fundamentals, technicals, and AI-driven analysis.

Get full analysis → Short-Term Analysis →

1-Year Price

2025-10-31 · $12.31 2026-10-30 · $10.94 (-11.13%)

Earnings

Most Recent

Aug 7, 2026

EPS $0.11 vs est. $0.11

Beat by $0.00

Next Earnings

Nov 10, 2026

EPS estimate $0.14

Proprietary Signals

Signal snapshot temporarily unavailable.

About Olympus Corporation

Olympus Corporation, alongside its affiliated companies, operates as a global enterprise specializing in the development and distribution of medical equipment. Its reach extends across Japan, the Americas, the Middle East, Asia, and Oceania. The company structures its operations around three primary divisions: Endoscopic Solutions, Therapeutic Solutions, and Other business segments. Its extensive product portfolio includes advanced gastrointestinal endoscopy systems, incorporating video and ultrasound technologies, as well as GI endotherapy tools for treating colorectal conditions, HPB (hepatopancreatobiliary) issues, and hemostasis. Olympus also delivers comprehensive endoscopic ecosystem solutions, which feature intelligent operating software platforms, AI-driven insights, and computer-aided detection and diagnosis functionalities. Furthermore, it provides reprocessing solutions for endoscopes, including reprocessors, chemicals, and related accessories, supported by essential medical services such as repair center operations. The company also supplies respiratory care devices, offering bronchoscopy systems and solutions for lung cancer and chronic obstructive pulmonary disease.…

Valuation

Trailing twelve months. Multiples relative to current market price.
P/E (TTM)	24.48×
P/S (TTM)	1.77×
P/B	2.50×
P/FCF (TTM)	25.94×
EV / EBITDA	11.07×
EV / Sales	1.96×
Earnings Yield	4.18%
Free Cash Flow Yield	3.86%
Dividend Yield	3.44%

Fundamentals

Trailing twelve months. Source: financial statements via market data.
Enterprise Value	$2.05T
Revenue (TTM)	$1.04T
Net Income (TTM)	$77.37B
Free Cash Flow (TTM)	$52.16B
Net Debt	$200.35B
Working Capital	$170.10B
Gross Margin	64.70%
Operating Margin	15.88%
Net Margin	7.49%
Return on Equity	10.21%
Return on Invested Capital	10.35%